Laminin 111 in mdx mouse

April 20 2009

Dr. Burkin published his results looking at laminin 111 therapy in the mdx mouse (Duchenne muscular dystrophy). Read more under Research News archive on prior research looking at laminin 111 in alpha 7 integrin (CMD) mouse model.

click here to see a Youtube video clip of an interview with Dr. Burkin.

Congenital Muscular Dystrophy

A group of diseases causing muscle weakness at birth. Several defined genetic mutations cause muscles to break down faster than they can repair or grow. A child with CMD may have various neurological or physical impairments. Some children never gain the ability to walk, while others lose the ability as they grow older. Learn more...
Events
- Fourth TREAT-NMD Curators’ Training Course
  - 5 September 2010
  - Paris, France
- CMD Scientific and Medical Advisory Board Meeting
  - 13 September 2010
- CMD Translational Grant Deadline
  - 15 September 2010
- Conference on Clinical Research for Rare Diseases
  - 21 September 2010
  - Bethesda, MD
- Cure CMD and NINDS: Common Data Elements Project meeting
  - 29 September 2010
Cure CMD Channel
Friends of Cure CMD
Navigation
Show Sub-Pages | Hide Sub-Pages

This website is for the discussion of Congenital muscular dystrophy (CMD) research, treatment and care issues. Please note that the ideas posted are the views of the individual, who may or may not be a licensed professional. Please consult with your doctors before implementing any treatment suggested here.

Copyright © Cure CMD | Designed by PressEnter! Creative | Powered by WordPress + Thematic, Events Manager, Sitemaps, Lightbox, Aggregation, TinyMCE, dTree, Category Posts

Laminin 111 in mdx mouse

April 20 2009

Congenital Muscular Dystrophy

Events

Navigation